Thyme Care
PrivateLast Round
Series E
Sep 2, 2026
Est. Valuation
$2B
Total Funding Raised
$399M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Thyme Care is a healthcare technology company that provides an oncology care platform to support cancer patients throughout their treatment journey with physician-guided nursing and resource specialists, enhancing access to quality care and actionable insights for early intervention.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Patient Engagement, Vertical SaaS, Medical AI
Business Model
B2B2C
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thyme Care Comparables
Compare Thyme Care with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atlas Oncology Partners | 78% | |
| Evolent Health | 77% | |
| OncoHealth | 76% |
Thyme Care Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Sep 2, 2026 | ||||
| Series D | Sep 25, 2025 | ||||
| Debt | Jul 16, 2024 | ||||
| Series C | Jul 16, 2024 | ||||
| Series B | Aug 22, 2023 | ||||
Series A | Oct 5, 2021 |
Key People
Founding team and executive leadership
Thyme Care Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series C, Series E, Series B, Series A, Series D |
| Town Hall Ventures | Series C, Series E, Series B, Series D |
| AlleyCorp | Series C, Series E, Series B, Series A, Series D |
| Frist Cressey Ventures | Series C, Series E, Series B, Series A, Series D |
| Texas Oncology | Series D |
| Foresite Capital | Series C, Series E, Series B, Series D |
| Morgan Health | Series D, Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
$125M round led by Morgan Health
- Jul 25, 2026
Monthly visitors increased 67% MoM.
Recent news
Latest coverage and updates
- promotesSep 4, 2026
Thyme Care, Inc. promoted Brad Diephuis to CEO on Jul 1st '26.
- recognized_asSep 2, 2026
Thyme Care, Inc. recognized as No. 18 on the 2026 CNBC Disruptor 50 on Sep 2nd '26.
- receives_financingSep 2, 2026
Thyme Care, Inc. received financing of $125M in Series E on Sep 2nd '26.
- hiresJul 15, 2026
Thyme Care, Inc hired Brad Diephuis as chief executive officer on Jul 1st '22.
- promotesJul 15, 2026
Thyme Care, Inc promoted Robin Shah to executive chairman on Jul 15th '26.
Thyme Care Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Thyme Care's valuation, stock price, and market status.
Is Thyme Care a public or private company?
Thyme Care is a private company.
What is the current stock price of Thyme Care?
Thyme Care is a private company with no public stock price. No recent secondary market data is available.
How much is Thyme Care worth (valuation)?
Thyme Care's valuation is estimated at $1.0B based on funding round data.
Can I buy Thyme Care stock?
Thyme Care shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Thyme Care's last funding round?
Thyme Care's most recent funding round was Series D on September 25, 2025.
Who are the main investors in Thyme Care?
Key investors in Thyme Care include Andreessen Horowitz, Town Hall Ventures, AlleyCorp, Frist Cressey Ventures, Foresite Capital.
Will Thyme Care IPO soon?
No public IPO plans have been announced for Thyme Care.
How can I track Thyme Care secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Thyme Care's secondary market activity and sign up for updates.